By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
An occlusion balloon catheter is a medical device used to temporarily stop or occlude a blood vessel, duct, or tube within the body during various medical operations.
It is made up of a flexible catheter with an inflating balloon attached to the tip.
The balloon can be inflated with a sterile liquid or gas to provide a temporary barrier, limiting or entirely blocking fluid or blood flow via the targeted conduit or channel.
Occlusion balloon catheters have numerous medical applications, including interventional radiology, cardiology, and other medical disciplines.
Occlusion balloon catheters are used in interventional radiology to obstruct blood arteries during procedures such as embolization.
The ability to place occlusion balloon catheters into small and difficult anatomical locations, as well as their transitory nature, allow for precise control during treatments.
They are often radiopaque, which means they may be visualized using medical imaging methods such as X-rays, fluoroscopy, or ultrasound to guarantee proper placement.
It is critical to highlight that occlusion balloon catheters should only be used by qualified medical experts who follow correct medical rules and practices.
Their appropriate application can make a considerable difference in the success of diagnostic and therapeutic operations.
Catheters of this type are also employed in gastrointestinal procedures.
They can, for example, be employed to temporarily occlude a segment of the intestine during surgery to prevent fluid passage.
The Global Occlusion Balloon Catheter Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
CERENOVUS, a Johnson & Johnson Medical Devices Companies company and a growing leader in neurovascular care, has announced the launch of EMBOGUARD, a next generation balloon guide catheter for use in endovascular treatments, including those for patients with acute ischemic stroke.
Schemic strokes account for 85%1 of all strokes worldwide, produced by the creation of a local blood clot or an embolus that travels to an artery in the brain and obstructs blood supply.
The suggested treatment option for acute ischemic stroke is mechanical thrombectomy (MT), a minimally invasive method to remove a clot.
2 The EMBOGUARD Balloon Guide Catheter is intended to maximize clot clearance during MT treatments by regulating blood flow locally.
3 The use of balloon guide catheters improves first-pass recanalization.
